Eralp, Y. Et Al. 2012. Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.. American Journal of Clinical Oncology , vol.20 , 1-5.

Eralp, Y., Keskin, S., YÖRÜKER, E. E., Yılmaz, E. Z., İĞCİ, A., MÜSLÜMANOĞLU, M. E., ... Yılmaz, S.(2012). Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.. American Journal of Clinical Oncology , vol.20, 1-5.

Eralp, Yeşim Et Al. "Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.," American Journal of Clinical Oncology , vol.20, 1-5, 2012

Eralp, Yeşim Et Al. "Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.." American Journal of Clinical Oncology , vol.20, pp.1-5, 2012

Eralp, Y. Et Al. (2012) . "Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.." American Journal of Clinical Oncology , vol.20, pp.1-5.

@article{article, author={Yeşim Eralp Et Al. }, title={Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2? Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.}, journal={American Journal of Clinical Oncology}, year=2012, pages={1-5} }